Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Estrogen affects scalp cell types differently, enhancing some wound healing processes.

Early minipulse corticosteroid therapy can effectively treat scalp discoid lupus in children.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Finasteride does not consistently cause depression.

The effects of estrogen on human hair growth are unclear and need more research.

Scientists found a way to grow human hair cells in a lab that can create new hair when transplanted.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

Analyzing hair with this method can help understand and monitor scalp conditions and treatment effects.

The glucose and NHA combination shows promise for hair regrowth.

A giant blue nevus on the scalp can cause hair loss and may damage underlying structures.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Wnt3a activates certain genes in hair follicle cells, including a newly discovered one, EP2, which may affect hair growth.

Different human hair follicle stem cells grow at different rates and respond differently to a baldness-related compound.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Middle-aged women with cicatricial alopecia/lichen planopilaris responded well to treatments like ketoconazole shampoo and steroids.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

The document suggests improvements for a hair and scalp disease book and recommends a two-volume skin surgery reference for dermatologists.

Botulinum toxin A may be an effective alternative treatment for the scalp disorder folliculitis decalvans.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

PRP with microneedling is generally safe but can cause minor side effects like scalp itching, temporary hair shedding, and swollen lymph nodes.

Trichogram is useful for diagnosing hair disorders, but newer, non-invasive methods like trichoscopy are becoming more popular due to their sensitivity and ability to monitor treatment responses.

Most hair loss cases are caused by four main conditions, and understanding them is key to treatment.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.